Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

672 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells.
Tabe Y, Hatanaka Y, Nakashiro M, Sekihara K, Yamamoto S, Matsushita H, Kazuno S, Fujimura T, Ikegami T, Nakanaga K, Matsumoto H, Ueno T, Aoki J, Yokomizo T, Konopleva M, Andreeff M, Miida T, Iwabuchi K, Sasai K. Tabe Y, et al. Among authors: hatanaka y. Int J Radiat Biol. 2016;92(1):24-34. doi: 10.3109/09553002.2015.1106021. Epub 2015 Nov 19. Int J Radiat Biol. 2016. PMID: 26809544
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.
Noguchi T, Ariga S, Moku R, Kikuchi J, Amano T, Maeda T, Ishikawa K, Maeda T, Shiiya A, Goda T, Ohhara Y, Hagio K, Saito Y, Hatanaka KC, Hatanaka Y, Taguchi J, Takeuchi S, Shimizu Y, Kinoshita I. Noguchi T, et al. Among authors: hatanaka y. JCO Precis Oncol. 2025 Jan;9:e2400437. doi: 10.1200/PO-24-00437. Epub 2025 Jan 17. JCO Precis Oncol. 2025. PMID: 39823560
Development of the membrane ceiling method for in vitro spermatogenesis.
Kamoshita M, Shirai H, Nakamura H, Kishimoto T, Hatanaka Y, Mashiko D, Esashika K, Yang J, Yamasaki S, Ogawa T, Kimura H, Ikawa M. Kamoshita M, et al. Among authors: hatanaka y. Sci Rep. 2025 Jan 3;15(1):625. doi: 10.1038/s41598-024-84965-1. Sci Rep. 2025. PMID: 39753886 Free PMC article.
Survivin as a therapeutic target for neuroendocrine neoplasms.
Hane Y, Tsuchikawa T, Nakamura T, Hatanaka KC, Sasaki K, Kawai N, Takeuchi S, Tanaka K, Nakanishi Y, Asano T, Noji T, Shichinohe T, Hatanaka Y, Hirohshi Y, Torigoe T, Hirano S. Hane Y, et al. Among authors: hatanaka y. Neuroendocrinology. 2025 Jan 2:1-31. doi: 10.1159/000543270. Online ahead of print. Neuroendocrinology. 2025. PMID: 39746333
Clinical Outcomes of Early WT1 mRNA Reduction After Remission Induction in Newly Diagnosed Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Tsushima T, Kimeda C, Yoda N, Matsuo K, Tanaka K, Hatanaka Y, Matsumoto R, Shimoji S, Utsu Y, Masuda SI, Aotsuka N. Tsushima T, et al. Among authors: hatanaka y. Transplant Cell Ther. 2024 Dec 16:S2666-6367(24)00807-8. doi: 10.1016/j.jtct.2024.12.007. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39694194 Free article.
LINC02154 promotes cell cycle and mitochondrial function in oral squamous cell carcinoma.
Niinuma T, Kitajima H, Sato T, Ogawa T, Ishiguro K, Kai M, Yamamoto E, Hatanaka Y, Nojima I, Toyota M, Yorozu A, Sekiguchi S, Tohse N, Furuhashi M, Ohguro H, Miyazaki A, Suzuki H. Niinuma T, et al. Among authors: hatanaka y. Cancer Sci. 2024 Nov 22. doi: 10.1111/cas.16379. Online ahead of print. Cancer Sci. 2024. PMID: 39576738 Free article.
672 results